HPE vs LXEO · P/E 20, rev $32.19B vs $147.7M cap
Hewlett Packard Enterprise Co (HPE) versus Lexeo Therapeutics, Inc. Common Stock (LXEO) — a side-by-side from cached financials, not a winner call.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
LXEO does not have a complete income-statement cache yet.
HPE currently screens at market cap $27.19B and trailing P/E 19.9. LXEO currently screens at market cap $147.7M.
Not investment advice. Open the HPE and LXEO stock pages for the full models.
Not investment advice.